OccuRx

OccuRx

Portfolio   Contact:   Dr Eric Daniels, CEOWebsite:   www.occurx.com OccuRx Pty Ltd is a start-up company from the University of Melbourne that is developing new drugs that treat the cause of blindness that occurs in some diabetics. Diabetic eye disease includes...
Nexgen

Nexgen

Portfolio   Contact:   Philippe Herve, CEO Website:   www.nexgenplants.com Nexgen INTtrait Nexgen Plants is a start-up company from the School of Agriculture and Food Sciences at the University of Queensland which is developing a novel platform technology that...
EnaRespiratory

EnaRespiratory

Portfolio   Contact:  Christophe Demaison, CEOWebsite:   www.enarespiratory.com Ena Respiratory is a biotechnology company spun out of the University of Melbourne that is developing novel, synthetic Toll-like receptor (TLR) agonists that have been shown to...
Exonate

Exonate

Portfolio   Contact:  Dr Catherine Beech OBE, CEOWebsite: https://www.exonate.com/ Exonate is a biopharmaceutical company that was formed on the on the basis of a medicinal chemistry program led by Associate Professor Jonathan Morris at the University of NSW and...
QUE Oncology

QUE Oncology

Portfolio   Contact:   Julie Cherrington CEOWebsite:   www.queoncology.com QUE Oncology, Inc. (QUE) was formed in 2013 through a collaboration between Emory University’s Institute for Drug Development (EIDD), in Atlanta, Georgia, and the University of Queensland...